BLAINE, WA--(MARKET WIRE)--Sep 25, 2008 -- Purio Inc. (OTC BB:PURO.OB - News) is pleased to report that it has received the first of two independent lab reports on water samples produced during its recent pair of demonstrations of their transportable water purification system. (see media release of Aug. 11, 2008).

"This lab report confirms results obtained from our on-board monitoring system," says Leonard Girard, Chief Science Officer with Purio. "Our first demonstration this season processed dirty water from an open pond located in a farming region of North Central Saskatchewan, Canada, during the hot mid-summer growing season. There were wild marsh plants and vegetation around the perimeter of the pond and wildlife such as waterfowl, insects and small animals in and around it. Our unit was set to process about 3250 USG (12,250 liters) per day. Our portable water clarification and purification unit is equipped with on-board testing monitors which display water quality parameters in real-time at several points along the treatment train during operation. These monitors gave us confidence that our unit was producing safe, aesthetically pleasing water at the time. Of course the most important area of concern is the unit's ability to eliminate E. coli and coliform bacteria which present serious risk to human health if ingested. Our monitors, as well as the accredited lab report (summarized below) both agree that the drinking water produced was clear, bacteria-free and sanitary."

Girard continues, "Pond water like this typically contains high levels of dissolved organic materials which could cause high levels of Trihalomethanes (commonly called THMs, such as Chloroform, many of which have been identified as carcinogens) if sanitized in conventional methods involving high levels of Chlorine or Chloramines. Our process does not use Chlorine at all and therefore we are able to produce a THM-free, therefore safer, healthier drinking water."

Earl Switenky, spokesman for Purio Inc., says, "Our compact unit is able to produce safe drinking water without any membrane filtration. This money-saving factor, coupled with our energy-efficient, process allows us to achieve such remarkable results while keeping our process cost low. The lab tested some 34 organic and inorganic analytes and the table below summarizes some of the most important ones which prove the powerful effectiveness of our clarifier and sanitizing chambers."

 
LAB REPORT SUMMARY TABLE:
Sample date: 12-08-08              RAW                FINISHED
Uranium                         7.3 ug/l              0.2 ug/l
pH                            8.34 pH units         7.96 pH units
Turbidity                        2.3 NTU               .6 NTU
E. coli                       66 MPN/100 mL              NR
Total coliform bacteria      720 MPN/100 mL              < 1


" < " not detected at level stated above
Most Probable Number (MPN) is equivalent to counts (CTS)
E. coli is not reported when total coliform is not detected.

About Purio Inc.

Purio owns proprietary water clarification technology suitable to a broad number of applications including the clarification of surface water, industrial process water and sewage. Purio intends to apply its technology initially to industrial and commercial applications to reclaim water and reduce the need for fresh water in such applications. Purio further intends to use its proprietary technology to produce potable water for commercial and residential use. Purio will commercialize its technology via a number of channels, namely licensing strategic partners to build and sell &/or operate units outside of North America, outright sale of their second generation (patent pending) units to end users and will build, own and operate on a fee for service basis their larger permanent installation units in North America.

Forward-Looking Statements

This press release "contains forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Since the forward-looking statements relate to future developments, results or events, these statements are highly speculative and involve risks, uncertainties and assumptions that are difficult to assess. You should not construe any of these statements as a definitive or invariable expression of what will actually occur or result. Such forward-looking statements in this press release include, among others, that the company will prove the testing results in a recognized and accepted format through an independent recognized lab, the transportability of the unit, or that the company's economical processing methods will open doors of possibilities around the world regarding drinking water.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, (i) the Company's ability to obtain and maintain adequate working capital requirements to operate Purio's business; (ii) the Company's ability to obtain necessary permits and approvals to operate Purio's business; (iii) the Company's ability to market and sell clarified and reclaimed water; and (iv) the Company's ability to negotiate and consummate license agreements for its water purification equipment. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although the Company believes that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance those beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consider all of the information set forth herein and should also refer to the risk factors disclosed in the Company's periodic reports filed from time to time with the Securities and Exchange Commission and available at www.sec.gov.

     Contact:
     Shawn Van Damme
     Investor Relations
     1-877-512-1120